Table 1 Baseline demographic and clinical characteristics of patients who underwent abdominal aortic replacement surgery and were extubated on the day of surgery (Group A) or on subsequent days (Group B)
Group A (n = 95) | Group B (n = 96) | Pvalue | |
|---|---|---|---|
Age (years) | 69±9 | 73±7 | 0.004 |
Height (cm) | 164.4±7.8 | 164.5±7.7 | 0.939 |
Weight (kg) | 60.3±8.8 | 62.9±12.5 | 0.166 |
Female | 11 (11.6%) | 12 (12.5%) | 0.845 |
Medical history | |||
Hypertension | 63 (66.3%) | 73 (76.0%) | 0.138 |
Diabetes mellitus | 20 (21.1%) | 23 (24.0%) | 0.631 |
Hyperlipidemia | 21 (22.1%) | 26 (27.1%) | 0.425 |
Chronic obstructive pulmonary disease | 7 (7.4%) | 4 (4.2%) | 0.372 |
Interstitial pneumonia | 1 (1.1%) | 2 (2.1%) | 1.000 |
Asthma | 4 (4.2%) | 1 (1.0%) | 0.211 |
Angina pectoris | 9 (9.5%) | 16 (16.7%) | 0.141 |
Previous cardiac surgery | 14 (14.7%) | 16 (16.7%) | 0.714 |
Coronary intervention | 15 (15.8%) | 28 (29.2%) | 0.027 |
Arrhythmia | 6 (6.3%) | 7 (7.3%) | 0.789 |
Cardiac disease | 2 (2.1%) | 3 (3.1%) | 1.000 |
Hemodialysis | 2 (2.1%) | 1 (1.0%) | 0.621 |
Medication | |||
Calcium channel blocking agent | 45 (47.4%) | 56 (58.3%) | 0.129 |
β receptor blocker | 17 (17.9%) | 18 (18.8%) | 0.879 |
ARB/ACEI | 43 (45.3%) | 48 (50.0%) | 0.512 |
Statin | 20 (21.1%) | 21 (21.9%) | 0.890 |